(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

F FIREBRICKPHARMA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

F FIREBRICKPHARMA

ST13

US500000079338107

Classe

5

Pedido

79338107

Registro

7159599

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

41

Atualização mais recente

02/01/2024

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5

Data de depósito

07/03/2022

Data de registro

12/09/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

12/09/2023

Última transação

12/09/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

5

Tipo de titular

82

Localização do titular

AU

Examinador

ELTON, DAVID

Unidade examinadora

L60

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of a stylized letter "F" followed by the wording "FIREBRICKPHARMA".

Titulares e representantes

Titulares

Firebrick Pharma Limited

Representantes

Lori Kozak Fox Rothschild LLP

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for the treatment and prevention of bacterial and viral infections and diseases; Pharmaceutical preparations for the treatment and prevention of dandruff; Pharmaceutical preparations for the treatment and prevention of bacteria that causes body odour; Pharmaceutical preparations for the treatment and prevention of respiratory diseases; Pharmaceutical preparations for the treatment and prevention of skin diseases; Pharmaceutical preparations for the treatment and prevention of nail fungus; anti-bacterial pharmaceutical preparations; iodine for pharmaceutical purposes; pharmaceutical preparations for health care for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for human use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for nasal use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for oral use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for personal use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for topical use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical products for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical products for use by humans for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for application to the body for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations in nasal spray form for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for the skinnailsscalp and body for the treatment and prevention of bacterial and viral infections and diseases

Publicações

Histórico de despachos e eventos da marca no USPTO.

41 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/01/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

13/12/2023

FIMP

FINAL DISPOSITION PROCESSED

13/12/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/12/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/09/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/09/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

27/06/2023

PUBO

PUBLISHED FOR OPPOSITION

27/06/2023

GPNX

NOTIFICATION PROCESSED BY IB

26/06/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/06/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/06/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/06/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

24/05/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

24/05/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

24/05/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

24/05/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

24/05/2023

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

24/05/2023

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

09/05/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

21/04/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

21/04/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

21/04/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

21/04/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

21/04/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

20/03/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

17/03/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

17/03/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

17/03/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

17/03/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

17/03/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/03/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

17/03/2023

RFNT

REFUSAL PROCESSED BY IB

06/03/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

15/02/2023

RFRR

REFUSAL PROCESSED BY MPU

15/02/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

21/12/2022

CNRT

NON-FINAL ACTION WRITTEN

20/12/2022

DOCK

ASSIGNED TO EXAMINER

17/12/2022

MAFR

APPLICATION FILING RECEIPT MAILED

19/04/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

15/04/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

14/04/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace F FIREBRICKPHARMA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.